Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Artivion has completed the acquisition of Endospan, a medical devices business in the U.S., for $116.3 million. Artivion acquires Endospan to expand its endoscopy and accessibility solutions portfolio, following FDA PMA approval of the NEXUS system. Endospan acquisition adds medical device capabilities designed for clinical use in healthcare settings, supporting Artivion acquisitions in the endoscopy market. The merger acquisition is a strategic acquisition by a strategic buyer, with the deal status marked closed and the PMA milestone enabling completion.
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026